Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paraneoplastic endocrine syndromes.
Dimitriadis GK, Angelousi A, Weickert MO, Randeva HS, Kaltsas G, Grossman A. Dimitriadis GK, et al. Among authors: weickert mo. Endocr Relat Cancer. 2017 Jun;24(6):R173-R190. doi: 10.1530/ERC-17-0036. Epub 2017 Mar 24. Endocr Relat Cancer. 2017. PMID: 28341725 Review.
Chemotherapy in NETs: When and how.
Angelousi A, Kaltsas G, Koumarianou A, Weickert MO, Grossman A. Angelousi A, et al. Among authors: weickert mo. Rev Endocr Metab Disord. 2017 Dec;18(4):485-497. doi: 10.1007/s11154-017-9432-1. Rev Endocr Metab Disord. 2017. PMID: 28890993 Review.
Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).
Xue M, Shafie A, Qaiser T, Rajpoot NM, Kaltsas G, James S, Gopalakrishnan K, Fisk A, Dimitriadis GK, Grammatopoulos DK, Rabbani N, Thornalley PJ, Weickert MO. Xue M, et al. Among authors: weickert mo. Oncotarget. 2017 Aug 16;8(44):76961-76973. doi: 10.18632/oncotarget.20290. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100361 Free PMC article.
Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours.
Mills L, Drymousis P, Vashist Y, Burdelski C, Prachalias A, Srinivasan P, Menon K, Cotoi C, Khan S, Cave J, Armstrong T, Weickert MO, Izbicki J, Schrader J, Frilling A, Ramage JK, Srirajaskanthan R. Mills L, et al. Among authors: weickert mo. Endocr Connect. 2017 Nov;6(8):876-885. doi: 10.1530/EC-17-0293. Endocr Connect. 2017. PMID: 29150545 Free PMC article.
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.
Pavel M, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, Anthony LB, Kunz PL, Hörsch D, Weickert MO, Lapuerta P, Jiang W, Kassler-Taub K, Wason S, Fleming R, Fleming D, Garcia-Carbonero R. Pavel M, et al. Among authors: weickert mo. Endocr Relat Cancer. 2018 Mar;25(3):309-322. doi: 10.1530/ERC-17-0455. Epub 2018 Jan 12. Endocr Relat Cancer. 2018. PMID: 29330194 Free PMC article. Clinical Trial.
Clock genes alterations and endocrine disorders.
Angelousi A, Kassi E, Nasiri-Ansari N, Weickert MO, Randeva H, Kaltsas G. Angelousi A, et al. Among authors: weickert mo. Eur J Clin Invest. 2018 Jun;48(6):e12927. doi: 10.1111/eci.12927. Epub 2018 Apr 16. Eur J Clin Invest. 2018. PMID: 29577261 Review.
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome.
Weickert MO, Kaltsas G, Hörsch D, Lapuerta P, Pavel M, Valle JW, Caplin ME, Bergsland E, Kunz PL, Anthony LB, Grande E, Öberg K, Welin S, Lombard-Bohas C, Ramage JK, Kittur A, Yang QM, Kulke MH. Weickert MO, et al. Clin Ther. 2018 Jun;40(6):952-962.e2. doi: 10.1016/j.clinthera.2018.04.006. Epub 2018 May 1. Clin Ther. 2018. PMID: 29724499 Free article. Clinical Trial.
166 results